In this Issue:
Platelet transfusion after antiplatelet-associated cerebral haemorrhage
RIC in mismatched-unrelated donor transplant for AML
Reduced intensity haplo- vs. double-cord transplant
High-dose R-CHOP then auto-SCT for higher risk DLBCL
Heterozygous STAT1 mutations underlie unexpectedly broad clinical phenotype
MRD monitoring and immune profiling in elderly MM
EBD vs. BD for relapsed/refractory MM
Increasing therapy intensity at diagnosis does not improve AML survival
TGF-α and IL-6 levels identify poor responders in chronic-phase CML
Please login below to download this issue (PDF)